indazoles has been researched along with methotrexate in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Battelli, T; De Gregorio, M; De Martino, C; Ginnetti, A; Giustini, L; Manocchi, P; Mattioli, R; Silvestrini, B | 1 |
Buccheri, G; Ferrigno, D | 1 |
Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F | 1 |
Nardini, S | 1 |
Buccheri, G; Ferrigno, D; Rosso, A | 1 |
Giovanelli, J; Kaufman, S; Witteveen, CF | 1 |
Boccalatte, FE; Bosia, A; Cheng, M; Chiarle, R; Comb, MJ; D'Amico, L; Goss, VL; Inghirami, G; Jensen, ON; Lee, K; Nardone, J; Polakiewicz, RD; Riera, L; Riganti, C; Ruggeri, B; Rush, J; Voena, C | 1 |
Baker, LH | 1 |
Ito, K; Koike, H; Nishida, Y; Sakai, T | 1 |
Italiano, A | 1 |
Orbach, D; Penel, N; Ryckewaert, T | 1 |
1 review(s) available for indazoles and methotrexate
Article | Year |
---|---|
Non small cell lung cancer and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Humans; Indazoles; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Staging; Treatment Outcome | 1994 |
3 trial(s) available for indazoles and methotrexate
Article | Year |
---|---|
A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG)
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Indazoles; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Survival Analysis | 1994 |
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Humans; Indazoles; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pilot Projects; Remission Induction; Survival Rate | 1993 |
7 other study(ies) available for indazoles and methotrexate
Article | Year |
---|---|
A long-term clinical experience with Lonidamine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Indazoles; Lomustine; Male; Methotrexate; Middle Aged; Pyrazoles; Tomography, X-Ray Computed | 1984 |
Reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase.
Topics: Animals; Arginine; Biopterins; Cell Line; Cerebellum; Enzyme Inhibitors; Humans; Indazoles; Kidney; Kinetics; Methotrexate; NADP; Nitric Oxide Synthase; Nitroarginine; Onium Compounds; Oxidation-Reduction; Rats; Recombinant Proteins; Transfection | 1996 |
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Carbazoles; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hydroxymethyl and Formyl Transferases; Indazoles; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Microfilament Proteins; Molecular Sequence Data; Multienzyme Complexes; Neoplasm Proteins; Nucleotide Deaminases; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Interaction Mapping; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Transcription, Genetic | 2009 |
The necessity for rigour in rare disease study design.
Topics: Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Rare Diseases; Research Design; Sulfonamides; Vinblastine | 2019 |
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost.
Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine | 2019 |
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost - Author's reply.
Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine | 2019 |
[Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions].
Topics: Adult; Age Factors; Antineoplastic Agents; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Over Studies; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Proof of Concept Study; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Vinblastine | 2020 |